stella
beta
MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP — Stella
Recruiting
Back to Diabetic Peripheral Neuropathic Pain trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Clinical Trials of Texas,LLC, Fredericksburg, Texas
View full record on ClinicalTrials.gov